Mechanisms of Estrogen-Induced Venous Thromboembolism

2010/02/17 by Svetlana N. Tchaikovski, Svetlana Tchaikovski, Jan Rosing · 9 citations
Medicine · #Blood Coagulation and Thrombosis Mechanisms #Coagulation, Bradykinin, Polyphosphates, and Angioedema #Venous Thromboembolism Diagnosis and Management

paper · doi:10.1016/j.thromres.2010.01.045

openalex publication_date 2010/02/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Cited by

• Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters
• Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis of the Eudravigilance database
• Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
• Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways
• Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk
• The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy
• Oral Contraceptives and HRT Risk of Thrombosis
• How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
• Venous thromboembolism prophylaxis using the Caprini score